{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:56:00Z","timestamp":1781661360688,"version":"3.54.5"},"reference-count":275,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,20]],"date-time":"2016-11-20T00:00:00Z","timestamp":1479600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ihj.2016.11.320","type":"journal-article","created":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T13:15:47Z","timestamp":1481289347000},"page":"S31-S49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"S3","title":["Management standards for stable coronary artery disease in India"],"prefix":"10.1016","volume":"68","author":[{"given":"Sundeep","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumitra","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshed J.","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.S.","family":"Sawhney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiny","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.S.","family":"Iyengar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.K.","family":"Bahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ihj.2016.11.320_bib1000","series-title":"The Top Ten Causes of Death Fact Sheet","author":"The World Health Organization","year":"2012"},{"key":"10.1016\/j.ihj.2016.11.320_bib1005","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib1010","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0735-1097(97)00213-1","article-title":"Pathology of unstable plaque: correlation with the clinical severity of acute coronary syndromes","volume":"30","author":"Depre","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1015","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/eurheartj\/ehp266","article-title":"The unstable plaque: a broken balance","volume":"30","author":"Crea","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib1020","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1161\/CIRCULATIONAHA.111.037283","article-title":"Mechanisms of coronary artery spasm","volume":"124","author":"Lanza","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2016.11.320_bib1025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/2321-449X.140228","article-title":"Clinical characteristics, angiographic profile and in hospital mortality in acute coronary syndrome patients in south Indian population","volume":"2","author":"Sharma","year":"2014","journal-title":"Heart India"},{"key":"10.1016\/j.ihj.2016.11.320_bib1030","first-page":"222","article-title":"Cardiovascular disease risk factors in Asian Indian population: a systematic review","volume":"4","author":"Nag","year":"2013","journal-title":"J Cardiovasc Dis Res"},{"key":"10.1016\/j.ihj.2016.11.320_bib1035","first-page":"OE08","article-title":"Vascular disease in young Indians (20\u201340 years): role of ischemic heart disease","volume":"10","author":"Dalal","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.ihj.2016.11.320_bib1040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-118-2-199301150-00001","article-title":"Value of the history and physical in identifying patients at increased risk for coronary artery disease","volume":"118","author":"Pryor","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1045","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.cjca.2014.05.013","article-title":"Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart disease","volume":"30","author":"Mancini","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1050","doi-asserted-by":"crossref","first-page":"e1000439","DOI":"10.1371\/journal.pmed.1000439","article-title":"Threshold haemoglobin levels and the prognosis of stable coronary disease: two new cohorts and a systematic review and meta-analysis","volume":"8","author":"Shah","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.atherosclerosis.2015.02.053","article-title":"Glycated hemoglobin and long-term prognosis in patients with suspected stable angina pectoris without diabetes mellitus: a prospective cohort study","volume":"240","author":"Rebnord","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ihj.2016.11.320_bib1060","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/j.1464-5491.2005.01643.x","article-title":"The impact of diabetes or elevated fasting blood glucose on cardiovascular prognosis in patients with stable angina pectoris","volume":"22","author":"Held","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12902-016-0108-8","article-title":"Glucose levels as a prognostic marker in patients with ST-segment elevation myocardial infarction: a case\u2013control study","volume":"16","author":"Karetnikova","year":"2016","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.ihj.2016.11.320_bib1070","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/S1885-5857(10)70252-8","article-title":"Prognostic value of resting heart rate in a broad population of patients with stable coronary artery disease: prospective single-center Cohort study","volume":"63","author":"Ruiz Ortiz","year":"2010","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"key":"10.1016\/j.ihj.2016.11.320_bib1075","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(08)61171-X","article-title":"Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2016.11.320_bib1080","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.jacc.2014.07.973","article-title":"Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes","volume":"64","author":"Johnson","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1085","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ijcard.2015.03.025","article-title":"Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in coronary artery disease: a systematic review and meta-analysis","volume":"184","author":"Deng","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1090","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ihj.2015.08.008","article-title":"Diagnosis of coronary microvascular dysfunction \u2013 present status","volume":"67","author":"Mittal","year":"2015","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib1095","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jcmg.2010.04.007","article-title":"Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health","volume":"3","author":"Schindler","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ihj.2016.11.320_bib1100","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s12350-011-9441-5","article-title":"The cardiac magnetic resonance (CMR) approach to assessing myocardial viability","volume":"18","author":"Arai","year":"2011","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1105","first-page":"189","article-title":"Silent myocardial ischemia: current perspectives and future directions","volume":"12","author":"Ahmed","year":"2007","journal-title":"Exp Clin Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/MCA.0b013e3282f27c0a","article-title":"Association of anemia with clinical outcomes in stable coronary artery disease","volume":"19","author":"da Silveira","year":"2008","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.ihj.2016.11.320_bib1115","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-0028-1087203","article-title":"Tools for predicting the risk of type 2 diabetes in daily practice","volume":"41","author":"Schwarz","year":"2009","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ihj.2016.11.320_bib1120","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1371\/journal.pmed.0040270","article-title":"Renal function and risk of coronary heart disease in general populations: new prospective study and systematic review","volume":"4","author":"Di Angelantonio","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1125","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"Ryd\u00e9n","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib1130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/hrt.2005.086975","article-title":"Euro Heart Survey I. Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart","volume":"93","author":"Bartnik","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.ihj.2016.11.320_bib1135","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/eurheartj\/ehi190","article-title":"Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease","volume":"26","author":"Diaz","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib1140","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/eurheartj\/ehi235","article-title":"Heart rate: a strong predictor of mortality in subjects with coronary artery disease","volume":"26","author":"Palatini","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib1145","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.CIR.80.1.87","article-title":"Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis","volume":"80","author":"Gianrossi","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2016.11.320_bib1150","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1161\/CIRCULATIONAHA.111.029660","volume":"124","author":"Shaw","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2016.11.320_bib1155","doi-asserted-by":"crossref","first-page":"e002486","DOI":"10.1136\/bmjopen-2012-002486","article-title":"Acute electrocardiographic changes during smoking: an observational study","volume":"3","author":"Ramakrishnan","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.ihj.2016.11.320_bib1160","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1186\/s12889-015-2489-4","article-title":"Meta-analysis of the association between second-hand smoke exposure and ischemic heart diseases, COPD and stroke","volume":"15","author":"Fischer","year":"2015","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ihj.2016.11.320_bib1165","first-page":"70","article-title":"Smokeless tobacco use and its implications in WHO South East Asia Region","volume":"50","author":"Dobe","year":"2006","journal-title":"Indian J Public Health"},{"key":"10.1016\/j.ihj.2016.11.320_bib1170","doi-asserted-by":"crossref","first-page":"b3060","DOI":"10.1136\/bmj.b3060","article-title":"Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis","volume":"339","author":"Boffetta","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ihj.2016.11.320_bib1175","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1157\/13123068","article-title":"The importance of treating tobacco dependence","volume":"61","author":"McRobbie","year":"2008","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1180","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1161\/CIRCULATIONAHA.112.103234","article-title":"Relationship between healthy diet and risk of cardiovascular disease among patients on drug therapies for secondary prevention: a prospective cohort study of 31 546 high-risk individuals from 40 countries","volume":"126","author":"Dehghan","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2016.11.320_bib1185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0007114514003341","article-title":"Effects of the Dietary Approach to Stop Hypertension (DASH) diet on cardiovascular risk factors: a systematic review and meta-analysis","volume":"113","author":"Siervo","year":"2015","journal-title":"Br J Nutr"},{"key":"10.1016\/j.ihj.2016.11.320_bib1190","doi-asserted-by":"crossref","first-page":"e110586","DOI":"10.1371\/journal.pone.0110586","article-title":"The association between a vegetarian diet and cardiovascular disease (CVD) risk factors in India: the Indian Migration Study","volume":"9","author":"Shridhar","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ihj.2016.11.320_bib1195","doi-asserted-by":"crossref","first-page":"e0139817","DOI":"10.1371\/journal.pone.0139817","article-title":"Dietary intervention for overweight and obese adults: comparison of low-carbohydrate and low-fat diets. A meta-analysis","volume":"10","author":"Sackner-Bernstein","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ihj.2016.11.320_bib1200","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4103\/0976-9668.136180","article-title":"Effect of excessive water intake on body weight, body mass index, body fat, and appetite of overweight female participants","volume":"5","author":"Vij","year":"2014","journal-title":"J Nat Sci Biol Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1205","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/ajcn\/84.2.274","article-title":"Intake of sugar-sweetened beverages and weight gain: a systematic review","volume":"84","author":"Malik","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ihj.2016.11.320_bib1210","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jacc.2009.02.084","article-title":"Omega-3 polyunsaturated fatty acids and cardiovascular diseases","volume":"54","author":"Lavie","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1215","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","volume":"33","author":"Perk","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib1220","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-0028-1128150","article-title":"Physical activity and all-cause mortality: an updated meta-analysis with different intensity categories","volume":"30","author":"Lollgen","year":"2009","journal-title":"Int J Sports Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1225","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1249\/MSS.0b013e3181c3aa7e","article-title":"Sedentary behaviors increase risk of cardiovascular disease mortality in men","volume":"42","author":"Warren","year":"2010","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.ihj.2016.11.320_bib1230","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/ije\/dyh168","article-title":"Physical activity and stroke. A meta-analysis of observational data","volume":"33","author":"Wendel-Vos","year":"2004","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1235","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1136\/heartjnl-2014-307119","article-title":"Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis","volume":"101","author":"Wang","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.ihj.2016.11.320_bib1240","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/ije\/dyl245","article-title":"Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis","volume":"36","author":"Sniderman","year":"2007","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1245","first-page":"163","article-title":"Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management","volume":"57","author":"Misra","year":"2009","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.ihj.2016.11.320_bib1250","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/0971-5916.164234","article-title":"Prevalence of generalized & abdominal obesity in urban & rural India \u2013 the ICMR-INDIAB Study (Phase-I) [ICMR-NDIAB-3]","volume":"142","author":"Pradeepa","year":"2015","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.ihj.2016.11.320_bib1255","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pop.2012.11.003","article-title":"Hyperlipidemia as a risk factor for cardiovascular disease","volume":"40","author":"Nelson","year":"2013","journal-title":"Prim Care"},{"key":"10.1016\/j.ihj.2016.11.320_bib1260","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.atherosclerosis.2011.06.012","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"217","author":"Catapano","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ihj.2016.11.320_bib1265","first-page":"461","article-title":"Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians \u2013 a population with the highest risk of premature coronary artery disease & diabetes","volume":"138","author":"Enas","year":"2013","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.ihj.2016.11.320_bib1270","doi-asserted-by":"crossref","first-page":"e0131434","DOI":"10.1371\/journal.pone.0131434","article-title":"Risk factors of coronary artery disease in secondary prevention \u2013 results from the AtheroGene \u2013 study","volume":"10","author":"Zengin","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ihj.2016.11.320_bib1275","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1056\/NEJM199903253401204","article-title":"Passive smoking and the risk of coronary heart disease \u2013 a meta-analysis of epidemiologic studies","volume":"340","author":"He","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1280","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ihj.2013.06.005","article-title":"Smokeless tobacco and cardiovascular disease in low and middle income countries","volume":"65","author":"Gupta","year":"2013","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib1285","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1079\/BJN2001382","article-title":"BMI does not accurately predict overweight in Asian Indians in northern India","volume":"86","author":"Dudeja","year":"2001","journal-title":"Br J Nutr"},{"key":"10.1016\/j.ihj.2016.11.320_bib1290","first-page":"170","article-title":"Receiver operating characteristics curve analysis of body fat & body mass index in dyslipidaemic Asian Indians","volume":"117","author":"Misra","year":"2003","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.ihj.2016.11.320_bib1295","first-page":"32","article-title":"Anthropometry and body composition in northern Asian Indian patients with type 2 diabetes: Receiver Operating Characteristics (ROC) Curve analysis of body mass index with percentage body fat as standard","volume":"16","author":"Vikram","year":"2003","journal-title":"Diab Nutr Metab"},{"key":"10.1016\/j.ihj.2016.11.320_bib1300","first-page":"73","article-title":"Receiver operating characteristic curve analysis of BMI and percentage body fat in type 2 diabetics of Punjab","volume":"48","author":"Singh","year":"2004","journal-title":"Indian J Physiol Pharmacol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1305","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2016.11.320_bib1310","first-page":"292","article-title":"Effect of preprocedural statin use on procedural myocardial infarction and major cardiac adverse events in percutaneous coronary intervention: a meta-analysis","volume":"20","author":"Ebrahimi","year":"2008","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1315","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1161\/CIRCULATIONAHA.112.000712","article-title":"High-dose statin therapy in patients with stable coronary artery disease: treating the right patients based on individualized prediction of treatment effect","volume":"127","author":"Dorresteijn","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2016.11.320_bib1320","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2016.11.320_bib1325","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.ihj.2016.11.320_bib1330","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/HJH.0b013e32832aa6b5","article-title":"When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal","volume":"27","author":"Zanchetti","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.ihj.2016.11.320_bib1335","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1097\/01.hjh.0000194120.42722.ac","article-title":"The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients","volume":"23","author":"Liu","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.ihj.2016.11.320_bib1340","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0140-6736(04)16456-8","article-title":"Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial","volume":"363","author":"Weber","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2016.11.320_bib1345","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2016.11.320_bib1350","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1355","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib1360","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1258\/smj.2011.011274","article-title":"The impact of \u03b2-blockers on mortality in stable angina: a meta-analysis","volume":"57","author":"Huang","year":"2012","journal-title":"Scott Med J"},{"key":"10.1016\/j.ihj.2016.11.320_bib1365","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.amjmed.2008.09.043","article-title":"Long-acting calcium antagonists in patients with coronary artery disease: a meta-analysis","volume":"122","author":"Bangalore","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1370","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0002-9149(94)90721-8","article-title":"Comparison of nifedipine gastrointestinal therapeutic system and atenolol on antianginal efficacies and exercise hemodynamic responses in stable angina pectoris","volume":"73","author":"Wallace","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1375","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0167-5273(96)02806-9","article-title":"Nifedipine gastrointestinal therapeutic system versus atenolol in stable angina pectoris. The Netherlands Working Group on Cardiovascular Research (WCN)","volume":"57","author":"de Vries","year":"1996","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1380","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/oxfordjournals.eurheartj.a014699","article-title":"The Total Ischemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischemic burden in 608 patients with stable angina. The TIBET Study Group","volume":"17","author":"Fox","year":"1996","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib1385","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1001\/jama.281.20.1927","article-title":"Meta-analysis of trials comparing \u03b2-blockers, calcium antagonists, and nitrates for stable angina","volume":"281","author":"Heidenreich","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ihj.2016.11.320_bib1390","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00019501-200212000-00008","article-title":"Efficacy of monotherapy compared with combined antianginal drugs in the treatment of chronic stable angina pectoris: a meta-analysis","volume":"13","author":"Klein","year":"2002","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.ihj.2016.11.320_bib1395","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2174\/1874192401307010046","article-title":"Diltiazem: a reversible cause of atrioventricular block \u2013 until proven otherwise","volume":"7","author":"Koskinas","year":"2013","journal-title":"Open Cardiovasc Med J"},{"issue":"11","key":"10.1016\/j.ihj.2016.11.320_bib1400","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart \u2013 an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1405","series-title":"Coronary Artery Disease: New Approaches Without Traditional Revascularisation","year":"2011"},{"key":"10.1016\/j.ihj.2016.11.320_bib1410","first-page":"26","article-title":"Trimetazidine effects on cardiac biomarkers in acute coronary syndrome","volume":"67","author":"Dalal","year":"2015","journal-title":"Heart Metab"},{"key":"10.1016\/j.ihj.2016.11.320_bib1415","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2125.1994.tb04276.x","article-title":"Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group","volume":"37","author":"Detry","year":"1994","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1420","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/FJC.0b013e31817bdd66","article-title":"Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy","volume":"51","author":"Belardinelli","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1425","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2165\/11316840-000000000-00000","article-title":"Effect of antianginal drugs in stable angina on predicted mortality risk after surviving a myocardial infarction: a preliminary study (METRO)","volume":"9","author":"Iyengar","year":"2009","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.ihj.2016.11.320_bib1430","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00045391-200501000-00006","article-title":"Trimetazidine in Angina Combination Therapy-the TACT study: trimetazidine versus conventional treatment in patients with stable angina pectoris in a randomized, placebo-controlled, multicenter study","volume":"12","author":"Chazov","year":"2005","journal-title":"Am J Ther"},{"key":"10.1016\/j.ihj.2016.11.320_bib1435","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1742-1241.2001.tb11029.x","article-title":"Combination therapy in angina: a review of combination haemodynamic treatment and the role of combined haemodynamic and cardio-metabolic agents","volume":"55","author":"Jackson","year":"2001","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ihj.2016.11.320_bib1440","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000446640","article-title":"Efficacy and safety of adjunctive trimetazidine therapy for acute myocardial infarction: a systematic review and meta-analysis","volume":"135","author":"Li","year":"2016","journal-title":"Cardiology"},{"key":"10.1016\/j.ihj.2016.11.320_bib1445","first-page":"58","article-title":"Textbook of pharmacology","volume":"30","author":"Seth","year":"1998","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1450","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2165\/00003088-200645050-00003","article-title":"Clinical pharmacokinetics of ranolazine","volume":"45","author":"Jerling","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ihj.2016.11.320_bib1455","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.amjcard.2013.11.070","article-title":"The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials","volume":"113","author":"Banon","year":"2014","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.ihj.2016.11.320_bib1460","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2003.11.045","article-title":"Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina","volume":"43","author":"Chaitman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1465","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jacc.2006.05.044","article-title":"Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial","volume":"48","author":"Stone","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1470","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","article-title":"Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial","volume":"291","author":"Chaitman","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ihj.2016.11.320_bib1475","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jacc.2008.12.053","volume":"53","author":"Scirica","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1480","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0140-6736(15)00459-6","article-title":"Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"387","author":"Weisz","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2016.11.320_bib1485","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/eurheartj\/ehn571","article-title":"Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving \u03b2-blocker therapy: a 4-month, randomized, placebo-controlled trial","volume":"30","author":"Tardif","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib1490","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.CIR.0000048143.25023.87","article-title":"Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial","volume":"107","author":"Borer","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2016.11.320_bib1495","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/eurheartj\/ehi586","article-title":"Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina","volume":"26","author":"Tardif","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib1500","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10557-011-6327-3","article-title":"Efficacy of ivabradine in combination with \u03b2-blocker versus uptitration of \u03b2-blocker in patients with stable angina","volume":"25","author":"Amosova","year":"2011","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.ihj.2016.11.320_bib1505","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2165\/00003495-200767030-00005","article-title":"Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial","volume":"67","author":"Ruzyllo","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.ihj.2016.11.320_bib1510","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1159\/000108387","article-title":"Long-term safety and efficacy of ivabradine in patients with chronic stable angina","volume":"108","author":"Lopez-Bescos","year":"2007","journal-title":"Cardiology"},{"key":"10.1016\/j.ihj.2016.11.320_bib1515","unstructured":"Agency EM. Procoralan Film-coated Tablets: Summary of Product Characteristics. Available from: http:\/\/www.ema.europa.eu; Accessed 19.09.16."},{"key":"10.1016\/j.ihj.2016.11.320_bib1520","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2165\/00003495-200060040-00007","article-title":"Nicorandil. An updated review of its use in ischemic heart disease with emphasis on its cardioprotective effects","volume":"60","author":"Markham","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.ihj.2016.11.320_bib1525","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(02)08265-X","article-title":"Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial","volume":"359","author":"IONA Study Group","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2016.11.320_bib1530","first-page":"213","article-title":"Comparison of the antiischemic and antianginal effects of nicorandil and amlodipine in patients with symptomatic stable angina pectoris: the SWAN study","volume":"2","author":"Swan Study Group","year":"1999","journal-title":"J Clin Basic Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1535","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0002-9149(90)91129-T","article-title":"Comparison of nicorandil and atenolol in stable angina pectoris","volume":"66","author":"Hughes","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1540","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1253\/circj.71.826","article-title":"Double-blind, multicenter, active-controlled, randomized clinical trial to assess the safety and efficacy of orally administered nicorandil in patients with stable angina pectoris in China","volume":"71","author":"Zhu","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.ihj.2016.11.320_bib1545","first-page":"205","article-title":"Safety and efficacy of nicorandil in chronic stable angina \u2013 a double blind comparative randomised trial with isosorbide mononitrate","volume":"4","author":"Udaykumar","year":"2003","journal-title":"J Indian Acad Clin Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1550","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1248\/yakushi.130.1549","article-title":"Systematic review on the short-term efficacy and safety of nicorandil for stable angina pectoris in comparison with those of \u03b2-blockers, nitrates and calcium antagonists","volume":"130","author":"Hanai","year":"2010","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.ihj.2016.11.320_bib1555","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.atherosclerosis.2010.11.032","article-title":"Long-term use of oral nicorandil stabilizes coronary plaque in patients with stable angina pectoris","volume":"214","author":"Izumiya","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ihj.2016.11.320_bib1560","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijcard.2010.05.019","article-title":"Nitrates for stable angina: a systematic review and meta-analysis of randomized clinical trials","volume":"146","author":"Wei","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1565","unstructured":"NICE Guidelines-Stable Angina, 2011. Available from: https:\/\/www.nice.org.uk\/guidance\/cg126\/evidence\/full-guideline-183176605; Accessed 07.11.16."},{"key":"10.1016\/j.ihj.2016.11.320_bib1570","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0002-9149(82)90518-5","article-title":"Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy","volume":"49","author":"Thadani","year":"1982","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1575","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0002-9149(93)91098-3","article-title":"Eccentric dosing with isosorbide-5-mononitrate in angina pectoris","volume":"72","author":"Parker","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1580","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/0002-9149(93)90292-K","article-title":"Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris","volume":"72","author":"Chrysant","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1585","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMcp1502240","article-title":"Clinical practice. Chronic stable angina","volume":"374","author":"Ohman","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1590","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijcard.2016.06.150","article-title":"Medical treatment of stable angina: a tailored therapeutic approach","volume":"220","author":"Manolis","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1595","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(95)90865-X","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2016.11.320_bib1600","first-page":"194","article-title":"Antianginal effect of transdermal nitroglycerin and oral nitrates given for 24h a day in 2,456 patients with stable angina pectoris. The Italian Multicenter Study","volume":"33","author":"Savonitto","year":"1995","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.ihj.2016.11.320_bib1605","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0735-1097(94)00436-T","article-title":"Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. Canadian Amlodipine\/Atenolol in Silent Ischemia Study (CASIS) Investigators","volume":"25","author":"Davies","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1610","first-page":"327","article-title":"Profound sinus bradycardia due to diltiazem, verapamil, and\/or beta-adrenergic blocking drugs","volume":"156","author":"Mills","year":"2004","journal-title":"JLa State Med Soc"},{"key":"10.1016\/j.ihj.2016.11.320_bib1615","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jacc.2004.03.057","article-title":"Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug","volume":"44","author":"Zeltser","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1620","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/0002-9149(94)90548-7","article-title":"Comparison between felodipine and isosorbide mononitrate as adjunct to beta blockade in patients > 65 years of age with angina pectoris","volume":"74","author":"de Vries","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1625","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jacc.2009.01.037","article-title":"Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebocontrolled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial","volume":"53","author":"Wilson","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1630","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.amjmed.2007.10.002","article-title":"Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis","volume":"121","author":"Berger","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1635","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy \u2013 I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists\u2019 Collaboration","volume":"308","author":"Trialists A","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.ihj.2016.11.320_bib1640","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Trialists\u2019 Collaboration A","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.ihj.2016.11.320_bib1645","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/0140-6736(92)92619-Q","article-title":"Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group","volume":"340","author":"Juul-Moller","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2016.11.320_bib1650","doi-asserted-by":"crossref","first-page":"835","DOI":"10.7326\/0003-4819-114-10-835","article-title":"Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial","volume":"114","author":"Ridker","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1655","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2016.11.320_bib1660","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1161\/CIR.0b013e3182776f83","volume":"126","author":"Fihn","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2016.11.320_bib1665","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa042087","article-title":"Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding","volume":"352","author":"Chan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1670","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","article-title":"Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET\/OFFSET study","volume":"120","author":"Gurbel","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2016.11.320_bib1675","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/eurheartj\/ehi877","article-title":"Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease","volume":"27","author":"Jernberg","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib1680","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ahj.2006.04.012","volume":"152","author":"Wiviott","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib1685","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(09)62191-7","article-title":"Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study","volume":"375","author":"Cannon","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ihj.2016.11.320_bib1690","article-title":"Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease","author":"Keller","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ihj.2016.11.320_bib1695","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1056\/NEJMoa1200933","article-title":"Vorapaxar in the secondary prevention of atherothrombotic events","volume":"366","author":"Morrow","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1700","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0140-6736(12)61269-0","article-title":"Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2 degrees P-TIMI 50 trial","volume":"380","author":"Scirica","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2016.11.320_bib1705","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0002-9343(76)90888-3","article-title":"The biochemistry of the renin\u2013angiotensin system and its role in hypertension","volume":"60","author":"Skeggs","year":"1976","journal-title":"Am J Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1710","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1097\/01.hjh.0000220405.38622.23","article-title":"Effect of angiotensin II type 1 receptor antagonism on endothelial function: role of bradykinin and nitric oxide","volume":"24","author":"Landmesser","year":"2006","journal-title":"J Hypertens Suppl"},{"key":"10.1016\/j.ihj.2016.11.320_bib1715","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1720","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)","volume":"362","author":"Fox","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2016.11.320_bib1725","first-page":"SR23","article-title":"Cardiovascular protection with ace inhibitors \u2013 more HOPE for EUROPA?","volume":"10","author":"Boos","year":"2004","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.ihj.2016.11.320_bib1730","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.jacc.2005.11.073","article-title":"Angiotensin-converting enzyme inhibitors in coronary artery disease and preserved left ventricular systolic function: a systematic review and meta-analysis of randomized controlled trials","volume":"47","author":"Al-Mallah","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1735","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ahj.2009.12.042","article-title":"Clinical synergy of perindopril and calcium-channel blocker in the prevention of cardiac events and mortality in patients with coronary artery disease. Post hoc analysis of the EUROPA study","volume":"159","author":"Bertrand","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib1740","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","volume":"366","author":"Dahlof","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2016.11.320_bib1745","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients","volume":"359","author":"Jamerson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1750","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1755","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1161\/CIRCULATIONAHA.105.594986","article-title":"Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox","volume":"114","author":"Strauss","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2016.11.320_bib1760","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","article-title":"Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial","volume":"372","author":"Mann","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2016.11.320_bib1765","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.jacc.2008.08.039","article-title":"Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients","volume":"52","author":"Mills","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1770","first-page":"Cd004816","article-title":"Statins for the primary prevention of cardiovascular disease","volume":"1","author":"Taylor","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ihj.2016.11.320_bib1775","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jacc.2006.04.070","article-title":"Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy","volume":"48","author":"Cannon","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1780","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jacc.2014.04.042","article-title":"beta-Blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease","volume":"64","author":"Andersson","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1785","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jama.2012.12559","article-title":"beta-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease","volume":"308","author":"Bangalore","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ihj.2016.11.320_bib1790","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.amjmed.2014.05.032","article-title":"Clinical outcomes with beta-blockers for myocardial infarction: a meta-analysis of randomized trials","volume":"127","author":"Bangalore","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1795","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.297.16.1775","article-title":"Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial","volume":"297","author":"Morrow","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ihj.2016.11.320_bib1800","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","article-title":"Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2016.11.320_bib1805","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa1406430","article-title":"Ivabradine in stable coronary artery disease without clinical heart failure","volume":"371","author":"Fox","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1810","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.jtcvs.2014.11.002","volume":"149","author":"Fihn","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ihj.2016.11.320_bib1815","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2014.02.012","article-title":"EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: the factorial group results of the Trial to Assess Chelation Therapy","volume":"168","author":"Lamas","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib1820","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.103.3.363","article-title":"Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery","volume":"103","author":"Bhatt","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2016.11.320_bib1825","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/01.STR.0000110221.54366.49","article-title":"Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events Investigators. Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events","volume":"35","author":"Ringleb","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.ihj.2016.11.320_bib1830","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/2048872612441580","article-title":"A strategy for addressing aspirin hypersensitivity in patients requiring urgent PCI","volume":"1","author":"Schiano","year":"2012","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.ihj.2016.11.320_bib1835","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1840","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1845","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijcard.2006.08.082","article-title":"Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease","volume":"120","author":"Marazzi","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1850","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ijcard.2012.11.001","article-title":"Efficacy of trimetazidine on functional capacity in symptomatic patients with stable exertional angina \u2013 the VASCO-angina study","volume":"168","author":"Vitale","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1855","doi-asserted-by":"crossref","first-page":"185A","DOI":"10.1016\/S0895-7061(01)01639-9","article-title":"P-459: exercise-induced and silent ischemia: different effects of monotherapy","volume":"14","author":"Kikalishvili","year":"2001","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ihj.2016.11.320_bib1860","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40261-014-0170-9","volume":"34","author":"Xu","year":"2014","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.ihj.2016.11.320_bib1865","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/021849239900700203","article-title":"Myocardial ischemia after coronary bypass: comparison of Trimetazidine and Diltiazem","volume":"7","author":"Kuralay","year":"1999","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"10.1016\/j.ihj.2016.11.320_bib1870","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/01.hjh.0000467430.64806.58","article-title":"2D.09: the effect of ivabradine on silent ambulatory myocardial ischemia","volume":"33","author":"Kadro","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/j.ihj.2016.11.320_bib1875","first-page":"25","article-title":"The effects of ranolazine on paroxysmal atrial fibrillation in patients with coronary artery disease: a preliminary observational study","volume":"6","author":"Leftheriotis","year":"2014","journal-title":"JAFIB: J Atrial Fibril"},{"key":"10.1016\/j.ihj.2016.11.320_bib1880","doi-asserted-by":"crossref","first-page":"P4113","DOI":"10.1093\/eurheartj\/eht309.P4113","article-title":"The effects of ranolazine on paroxysmal atrial fibrillation in patients with coronary artery disease","volume":"34","author":"Leftheriotis","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib1885","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1517\/14656566.2012.740458","article-title":"Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal","volume":"13","author":"Thadani","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ihj.2016.11.320_bib1890","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jacc.2011.07.050","article-title":"Silent ischemia: clinical relevance","volume":"59","author":"Conti","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1895","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jcmg.2014.12.008","article-title":"Coronary microvascular dysfunction, microvascular angina, and treatment strategies","volume":"8","author":"Marinescu","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ihj.2016.11.320_bib1900","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0002-9149(99)00450-6","article-title":"Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X","volume":"84","author":"Lanza","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1905","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0002-9149(89)90332-9","article-title":"Comparison of verapamil versus propranolol therapy in syndrome X","volume":"63","author":"Bugiardini","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1910","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10557-006-0494-7","article-title":"Does the beta-blocker nebivolol increase coronary flow reserve?","volume":"21","author":"Togni","year":"2007","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.ihj.2016.11.320_bib1915","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/euhj.2000.2152","article-title":"Therapeutic options for the management of patients with cardiac syndrome X","volume":"22","author":"Kaski","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib1920","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/clc.4960220513","article-title":"Antianginal and anti-ischemic effects of nisoldipine and ramipril in patients with syndrome X","volume":"22","author":"Ozcelik","year":"1999","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1925","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0002-9149(85)90842-2","article-title":"Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve","volume":"56","author":"Cannon","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1930","first-page":"382086","article-title":"Short-term effects of verapamil and diltiazem in the treatment of no reflow phenomenon: a meta-analysis of randomized controlled trials","volume":"2015","author":"Wang","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ihj.2016.11.320_bib1935","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00019501-200003000-00012","article-title":"Effects of trimetazidine on clinical symptoms and tolerance of exercise of patients with syndrome X: a preliminary study","volume":"11","author":"Rogacka","year":"2000","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.ihj.2016.11.320_bib1940","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF01616842","article-title":"The effect of trimetazidine in the treatment of microvascular angina","volume":"8","author":"Nalbantgil","year":"1999","journal-title":"Int J Angiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1945","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.amjcard.2013.02.045","article-title":"Effects of ivabradine and ranolazine in patients with microvascular angina pectoris","volume":"112","author":"Villano","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1950","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jcmg.2011.03.007","article-title":"Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease","volume":"4","author":"Mehta","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ihj.2016.11.320_bib1955","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/0735-1097(89)90382-3","article-title":"Spontaneous coronary artery spasm in variant angina is caused by a local hyperreactivity to a generalized constrictor stimulus","volume":"14","author":"Kaski","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1960","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/1074248416640161","article-title":"Pharmacotherapy of vasospastic angina","volume":"21","author":"Harris","year":"2016","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.ihj.2016.11.320_bib1965","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/1573402110666140131161338","article-title":"Vasospastic angina and Ca channel blockers","volume":"9","author":"Minatoguchi","year":"2013","journal-title":"Curr Hypertens Rev"},{"key":"10.1016\/j.ihj.2016.11.320_bib1970","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/0002-9149(88)91238-6","article-title":"Refractory variant angina relieved by guanethidine and clonidine","volume":"62","author":"Frenneaux","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib1975","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1378\/chest.123.2.380","article-title":"Limitations of medical therapy in patients with pure coronary spastic angina","volume":"123","author":"Sueda","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.ihj.2016.11.320_bib1980","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1253\/circj.CJ-10-74-0802","article-title":"Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2008): digest version","volume":"74","year":"2010","journal-title":"Circ J"},{"issue":"1","key":"10.1016\/j.ihj.2016.11.320_bib1985","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.CIR.0000047041.66447.29","volume":"107","author":"Gibbons","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2016.11.320_bib1990","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/jamainternmed.2013.12855","article-title":"Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials","volume":"174","author":"Stergiopoulos","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib1995","doi-asserted-by":"crossref","first-page":"g3859","DOI":"10.1136\/bmj.g3859","article-title":"Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis","volume":"348","author":"Windecker","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ihj.2016.11.320_bib2000","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib2005","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/CIRCULATIONAHA.109.911669","article-title":"Ten-year follow-up survival of the medicine. Angioplasty, or surgery study (MASS II). A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease","volume":"122","author":"Hueb","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2016.11.320_bib2010","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/S0140-6736(09)60552-3","article-title":"Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials","volume":"373","author":"Hlatky","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2016.11.320_bib2015","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.amjmed.2008.07.027","article-title":"The impact of revascularisation on mortality in patients with nonacute coronary artery disease","volume":"122","author":"Jeremias","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib2020","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1161\/CIRCULATIONAHA.104.521864","article-title":"Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis","volume":"111","author":"Katritsis","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2016.11.320_bib2025","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jacc.2008.05.051","article-title":"A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease","volume":"52","author":"Schomig","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib2030","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(09)60319-6","article-title":"Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis","volume":"373","author":"Trikalinos","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2016.11.320_bib2035","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/CIRCINTERVENTIONS.112.970954","article-title":"Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials","volume":"5","author":"Pursnani","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ihj.2016.11.320_bib2040","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2016.11.320_bib2045","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1161\/CIRCULATIONAHA.112.097014","article-title":"Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials","volume":"125","author":"Bangalore","year":"2012","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ihj.2016.11.320_bib2050","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ihj.2016.08.012","article-title":"Are all stents equal-Need for scoring system to evaluate stents","volume":"68","author":"Mishra","year":"2016","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib2055","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(94)91963-1","article-title":"Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration","volume":"344","author":"Yusuf","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2016.11.320_bib2060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ihj.2016.01.003","article-title":"Does modern medicine increase life-expectancy: quest for the Moon Rabbit?","volume":"68","author":"Mishra","year":"2016","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib2065","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1540-8183.2010.00598.x","article-title":"An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart. Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)","volume":"23","author":"Khuddus","year":"2010","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib2070","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators","volume":"355","author":"Heart Outcomes Prevention Evaluation (HOPE) Study Investigators","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2016.11.320_bib2075","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/joic.12142","article-title":"Cardioprotective effects of oral nicorandil use in diabetic patients undergoing elective percutaneous coronary intervention","volume":"27","author":"Shehata","year":"2014","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib2080","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"issue":"9590","key":"10.1016\/j.ihj.2016.11.320_bib2085","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2016.11.320_bib2090","first-page":"223","article-title":"Major findings from ADVANCE: blood pressure lowering arm","volume":"31","author":"Poulter","year":"2009","journal-title":"Medicographia"},{"key":"10.1016\/j.ihj.2016.11.320_bib2095","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1056\/NEJMoa1407963","article-title":"ADVANCE-ON Collaborative Group. Follow-up of blood-pressure lowering and glucose control in type 2 diabetes","volume":"371","author":"Zoungas","year":"2014","journal-title":"N Engl J Med"},{"issue":"1\u20132","key":"10.1016\/j.ihj.2016.11.320_bib2100","first-page":"89","article-title":"Efficacy of metformin as initial therapy in patients with coronary artery disease and diabetes type 2","author":"Lavrenko","year":"2011","journal-title":"Lik Sprava"},{"key":"10.1016\/j.ihj.2016.11.320_bib2105","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2337\/dc12-0719","article-title":"Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease","volume":"36","author":"Hong","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ihj.2016.11.320_bib2110","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/eurheartj\/ehr077","article-title":"Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study","volume":"32","author":"Schramm","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib2115","series-title":"Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine","author":"Braunwald","year":"2014"},{"key":"10.1016\/j.ihj.2016.11.320_bib2120","first-page":"1094","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"374","author":"Zinman","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib2125","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","author":"Frye","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ihj.2016.11.320_bib2130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S2213-8587(13)70089-5","article-title":"Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials","volume":"1","author":"Verma","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ihj.2016.11.320_bib2135","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2016.06.021","article-title":"Medical treatment and revascularisation options in patients with type 2 diabetes and coronary disease","volume":"68","author":"Mancini","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib2140","first-page":"16","article-title":"Coronary revascularisation in diabetic patients: current state of evidence","volume":"16","author":"Singh","year":"2011","journal-title":"Exp Clin Cardiol"},{"issue":"1","key":"10.1016\/j.ihj.2016.11.320_bib2145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0735-1097(02)02663-3","article-title":"Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community","volume":"41","author":"Manjunath","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib2150","first-page":"461","article-title":"Using ACE inhibitors appropriately","volume":"66","author":"Bicket","year":"2002","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ihj.2016.11.320_bib2155","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1378\/chest.125.3.1124","article-title":"Prognostic value of stress testing in patients over 75 years of age with chronic angina","volume":"125","author":"Jeger","year":"2004","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.ihj.2016.11.320_bib2160","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/01.CIR.39.6.759","article-title":"Comparative effects of aging and coronary heart disease on submaximal and maximal exercise","volume":"39","author":"Kasser","year":"1969","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2016.11.320_bib2165","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.amjcard.2009.05.056","article-title":"Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularisation and Aggressive DruG Evaluation (COURAGE) trial","volume":"104","author":"Maron","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib2170","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jama.289.9.1117","article-title":"Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial","volume":"289","author":"Pfisterer","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ihj.2016.11.320_bib2175","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJM198908033210507","article-title":"Management of drug therapy in the elderly","volume":"321","author":"Montamat","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib2180","first-page":"109","article-title":"Stable ischemic heart disease in the older adults","volume":"13","author":"Dai","year":"2016","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib2185","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1056\/NEJMoa025028","article-title":"Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly","volume":"348","author":"Nichol","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib2190","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/eurheartj\/ehm581","article-title":"Influenza vaccination in secondary prevention from coronary ischemic events in coronary artery disease: FLUCAD study","volume":"29","author":"Ciszewski","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib2195","doi-asserted-by":"crossref","first-page":"e2588","DOI":"10.1097\/MD.0000000000002588","article-title":"Influenza vaccination is associated with lower risk of acute coronary syndrome in elderly patients with chronic kidney disease","volume":"95","author":"Chen","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ihj.2016.11.320_bib2200","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(01)06100-1","article-title":"Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2016.11.320_bib2205","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1161\/01.CIR.0000140983.69571.BA","article-title":"Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME)","volume":"110","author":"Pfisterer","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2016.11.320_bib2210","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0002-9149(02)03240-X","article-title":"Comparison of presentation, perception, and six-month outcome between women and men > or =75 years of age with angina pectoris","volume":"91","author":"Kuster","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib2215","first-page":"2501","article-title":"Guidelines on myocardial revascularisation","volume":"31","author":"Wijns","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib2220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/HJR.0b013e3283313592","article-title":"Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation","volume":"17","author":"Piepoli","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.ihj.2016.11.320_bib2225","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.jacc.2004.08.064","article-title":"Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study","volume":"44","author":"Goldman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib2230","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/0735-1097(96)00206-9","article-title":"Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years","volume":"28","author":"Fitzgibbon","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib2235","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1161\/CIRCOUTCOMES.110.958744","article-title":"Trends in coronary revascularisation in the United States from 2001 to 2009: recent declines in percutaneous coronary intervention volumes","volume":"4","author":"Riley","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ihj.2016.11.320_bib2240","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.amjcard.2004.12.065","article-title":"Effect of chronic total coronary occlusion on treatment strategy","volume":"95","author":"Christofferson","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib2245","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0002-8703(93)90404-W","article-title":"Angiographic suitability for catheter revascularisation of total coronary occlusions in patients from a community hospital setting","volume":"126","author":"Kahn","year":"1993","journal-title":"Am Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib2250","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jacc.2011.12.007","article-title":"Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry","volume":"59","author":"Fefer","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib2255","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1631\/jzus.B1201009","article-title":"Current status of percutaneous coronary intervention of chronic total occlusion","volume":"13","author":"Ge","year":"2012","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.ihj.2016.11.320_bib2260","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1056\/NEJMoa040316","article-title":"Long-term outcomes of coronary-artery bypass grafting versus stent implantation","volume":"352","author":"Hannan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2016.11.320_bib2265","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1161\/CIRCULATIONAHA.106.612267","article-title":"Impact of completeness of percutaneous coronary intervention revascularisation on long-term outcomes in the stent era","volume":"113","author":"Hannan","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2016.11.320_bib2270","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0735-1097(90)90285-W","article-title":"Procedural outcome of angioplasty for total coronary artery occlusion: an analysis of 971 lesions in 905 patients","volume":"15","author":"Stone","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib2275","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jcin.2009.04.008","article-title":"Procedural and in-hospital outcomes after percutaneous coronary intervention for chronic total occlusions of coronary arteries 2002 to 2008: impact of novel guidewire techniques","volume":"2","author":"Rathore","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ihj.2016.11.320_bib2280","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jcin.2012.05.017","article-title":"Comparative effectiveness of drug-eluting versus bare-metal stents in elderly patients undergoing revascularisation of chronic total coronary occlusions: results from the National Cardiovascular Data Registry, 2005\u20132008","volume":"5","author":"Patel","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ihj.2016.11.320_bib2285","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/eurheartj\/ehq199","article-title":"Comparison of sirolimus-eluting and bare metal stent for treatment of patients with total coronary occlusions: results of the GISSOC II-GISE multicentre randomized trial","volume":"31","author":"Rubartelli","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2016.11.320_bib2290","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.4244\/EIJV7I10A190","volume":"7","author":"Van den Branden","year":"2012","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ihj.2016.11.320_bib2295","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4244\/EIJV6I3A59","article-title":"Short and long term comparison (24 months) of an alternative sirolimus-coated stent with bioabsorbable polymer and a bare metal stent of similar design in chronic coronary occlusions: the CORACTO trial","volume":"6","author":"Reifart","year":"2010","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ihj.2016.11.320_bib2300","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.jacc.2009.12.038","article-title":"Efficacy and safety of drug-eluting stents in chronic total coronary occlusion recanalization: a systematic review and meta-analysis","volume":"55","author":"Colmenarez","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib2305","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/bmj.39106.476215.BE","article-title":"Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery","volume":"334","author":"Aziz","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.ihj.2016.11.320_bib2310","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0735-1097(99)00140-0","article-title":"The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes","volume":"33","author":"Arora","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib2315","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1527-5299.2007.05989.x","article-title":"Impact of external counterpulsation treatment on emergency department visits and hospitalizations in refractory angina patients with left ventricular dysfunction","volume":"13","author":"Soran","year":"2007","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.ihj.2016.11.320_bib2320","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.amjcard.2005.07.122","article-title":"Two-year clinical outcomes after enhanced external counterpulsation (EECP) therapy in patients with refractory angina pectoris and left ventricular dysfunction (report from The International EECP Patient Registry)","volume":"97","author":"Soran","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib2325","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/clc.20117","article-title":"Enhanced external counterpulsation in the treatment of chronic refractory angina: a long-term follow-up outcome from the International Enhanced External Counterpulsation Patient Registry","volume":"31","author":"Loh","year":"2008","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib2330","doi-asserted-by":"crossref","first-page":"488","DOI":"10.5694\/j.1326-5377.1993.tb137584.x","article-title":"TENS in refractory angina pectoris. Three case reports","volume":"158","author":"West","year":"1993","journal-title":"Med J Aust"},{"key":"10.1016\/j.ihj.2016.11.320_bib2335","doi-asserted-by":"crossref","DOI":"10.1016\/S0735-1097(14)61574-6","article-title":"Transcutaneous electrical nerve stimulation in refractory angina","volume":"63","author":"Irurita","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2016.11.320_bib2340","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2261-9-13","article-title":"Spinal cord stimulation in the treatment of refractory angina: systematic review and meta-analysis of randomised controlled trials","volume":"9","author":"Taylor","year":"2009","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.ihj.2016.11.320_bib2345","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/01.CIR.97.12.1157","article-title":"Electrical stimulation versus coronary artery bypass surgery in severe angina pectoris: the ESBY study","volume":"97","author":"Mannheimer","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2016.11.320_bib2350","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1592\/phco.30.7.639","article-title":"Impact of enhanced external counterpulsation on Canadian Cardiovascular Society angina class in patients with chronic stable angina: a meta-analysis","volume":"30","author":"Shah","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ihj.2016.11.320_bib2355","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/hrt.2009.185769","article-title":"NICE evaluation of transmyocardial laser revascularisation and percutaneous laser revascularisation for refractory angina","volume":"96","author":"Schofield","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.ihj.2016.11.320_bib2360","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/hrt.2010.208751","article-title":"Trimetazidine: a meta-analysis of randomised controlled trials in heart failure","volume":"97","author":"Gao","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.ihj.2016.11.320_bib2365","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ihj.2016.11.320_bib2370","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ihj.2016.11.318","article-title":"Management of stable coronary artery disease in India: executive summary","volume":"68","author":"Mishra","year":"2016","journal-title":"Indian Heart J"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483216309403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483216309403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T07:06:43Z","timestamp":1692601603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483216309403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":275,"alternative-id":["S0019483216309403"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2016.11.320","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management standards for stable coronary artery disease in India","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2016.11.320","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India.","name":"copyright","label":"Copyright"}]}}